French Introduce Time Limit For Drug Approval Applications After Compassionate-Use Award
Companies wanting to make their unapproved products available to patients under the “temporary use authorization” are facing some changes to the way the rules are implemented.
You may also be interested in...
An alliance of patient organizations for rare diseases says most EU member states are not doing enough to help patients with life-threatening diseases get timely access to innovative drugs on compassionate grounds. A time difference of more than three years may exist between patients benefiting from a compassionate use treatment, depending on where they live.
The UK government says it is on track to vaccinate the 15 million most vulnerable people by mid-February, and that a “major study” is under way to assess the potential impact of the new UK variant on vaccine efficacy.
Coronavirus Notebook: EU To Buy 30 Million Doses Of Valneva Vaccine, Russia To Issue Compulsory License For Remdesivir
The European Medicines Agency says hacked COVID-19 vaccine data has been leaked online, and Australia’s chief medical officer defends the Oxford/AstraZeneca vaccine against scientists’ claim that it is not effective enough.